Shenzhen YHLO Biotech Co., Ltd.

SHSE:688575 Stock Report

Market Cap: CN¥10.3b

Shenzhen YHLO Biotech Future Growth

Future criteria checks 5/6

Shenzhen YHLO Biotech is forecast to grow earnings and revenue by 38.9% and 24.9% per annum respectively. EPS is expected to grow by 38.9% per annum. Return on equity is forecast to be 18.5% in 3 years.

Key information

38.9%

Earnings growth rate

38.9%

EPS growth rate

Medical Equipment earnings growth26.6%
Revenue growth rate24.9%
Future return on equity18.5%
Analyst coverage

Good

Last updated06 Nov 2024

Recent future growth updates

Recent updates

We Think That There Are More Issues For Shenzhen YHLO Biotech (SHSE:688575) Than Just Sluggish Earnings

Nov 06
We Think That There Are More Issues For Shenzhen YHLO Biotech (SHSE:688575) Than Just Sluggish Earnings

Slammed 25% Shenzhen YHLO Biotech Co., Ltd. (SHSE:688575) Screens Well Here But There Might Be A Catch

Nov 04
Slammed 25% Shenzhen YHLO Biotech Co., Ltd. (SHSE:688575) Screens Well Here But There Might Be A Catch

Estimating The Intrinsic Value Of Shenzhen YHLO Biotech Co., Ltd. (SHSE:688575)

Oct 31
Estimating The Intrinsic Value Of Shenzhen YHLO Biotech Co., Ltd. (SHSE:688575)

Shenzhen YHLO Biotech (SHSE:688575) Is Reinvesting At Lower Rates Of Return

Oct 12
Shenzhen YHLO Biotech (SHSE:688575) Is Reinvesting At Lower Rates Of Return

Shenzhen YHLO Biotech Co., Ltd.'s (SHSE:688575) Price In Tune With Earnings

Aug 30
Shenzhen YHLO Biotech Co., Ltd.'s (SHSE:688575) Price In Tune With Earnings

Does Shenzhen YHLO Biotech (SHSE:688575) Have A Healthy Balance Sheet?

Jul 18
Does Shenzhen YHLO Biotech (SHSE:688575) Have A Healthy Balance Sheet?

Shenzhen YHLO Biotech Co., Ltd. (SHSE:688575) Not Lagging Market On Growth Or Pricing

May 23
Shenzhen YHLO Biotech Co., Ltd. (SHSE:688575) Not Lagging Market On Growth Or Pricing

Shenzhen YHLO Biotech's (SHSE:688575) Sluggish Earnings Might Be Just The Beginning Of Its Problems

May 01
Shenzhen YHLO Biotech's (SHSE:688575) Sluggish Earnings Might Be Just The Beginning Of Its Problems

There Are Reasons To Feel Uneasy About Shenzhen YHLO Biotech's (SHSE:688575) Returns On Capital

Mar 19
There Are Reasons To Feel Uneasy About Shenzhen YHLO Biotech's (SHSE:688575) Returns On Capital

Earnings and Revenue Growth Forecasts

SHSE:688575 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20263,3707782667885
12/31/20252,713594496927
12/31/20242,161435-166677
9/30/20241,90228966735N/A
6/30/20241,938387-36613N/A
3/31/20241,824340-339359N/A
12/31/20232,053355-736-73N/A
9/30/20232,397424-333292N/A
6/30/20232,719488-214419N/A
3/31/20233,27158266663N/A
12/31/20223,9811,0121,0181,583N/A
9/30/20223,450923412933N/A
6/30/20222,967782381816N/A
3/31/20222,312678501813N/A
12/31/20211,178205-113260N/A
9/30/20211,147216-45253N/A
6/30/20211,118198-26230N/A
3/31/20211,020198-38230N/A
1/1/202199921193282N/A
12/31/2019877108-6068N/A
12/31/201872938-15730N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 688575's forecast earnings growth (38.9% per year) is above the savings rate (2.8%).

Earnings vs Market: 688575's earnings (38.9% per year) are forecast to grow faster than the CN market (25.9% per year).

High Growth Earnings: 688575's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 688575's revenue (24.9% per year) is forecast to grow faster than the CN market (13.8% per year).

High Growth Revenue: 688575's revenue (24.9% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 688575's Return on Equity is forecast to be low in 3 years time (18.5%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y